Characterization of NF-κB Reporter U937 Cells and Their Application for the Detection of Inflammatory Immune-Complexes

PLoS One. 2016 May 27;11(5):e0156328. doi: 10.1371/journal.pone.0156328. eCollection 2016.

Abstract

Our study tested the hypothesis that immunoglobulins differ in their ability to activate the nuclear factor-κB pathway mediated cellular responses. These responses are modulated by several properties of the immune complex, including the ratio of antibody isotypes binding to antigen. Immunoassays allow the measurement of antigen specific antibodies belonging to distinct immunoglobulin classes and subclasses but not the net biological effect of the combination of these antibodies. We set out to develop a biosensor that is suitable for the detection and characterization of antigen specific serum antibodies. We genetically modified the monocytoid U937 cell line carrying Fc receptors with a plasmid encoding NF-κB promoter-driven GFP. This clone, U937-NF-κB, was characterized with respect to FcR expression and response to solid-phase immunoglobulins. Human IgG3, IgG4 and IgG1 induced GFP production in a time- and dose-dependent manner, in this order of efficacy, while IgG2 triggered no activation at the concentrations tested. IgA elicited no response alone but showed significant synergism with IgG3 and IgG4. We confirmed the importance of activation via FcγRI by direct stimulation with monoclonal antibody and by competition assays. We used citrullinated peptides and serum from rheumatoid arthritis patients to generate immune complexes and to study the activation of U937-NF-κB, observing again a synergistic effect between IgG and IgA. Our results show that immunoglobulins have distinct pro-inflammatory potential, and that U937-NF-κB is suitable for the estimation of biological effects of immune-complexes, offering insight into monocyte activation and pathogenesis of antibody mediated diseases.

MeSH terms

  • Antigen-Antibody Complex / immunology
  • Antigen-Antibody Complex / metabolism*
  • Female
  • Green Fluorescent Proteins / genetics
  • Humans
  • Immunoglobulin A / immunology
  • Immunoglobulin G / immunology
  • Inflammation / immunology
  • Lipopolysaccharides / pharmacology
  • Male
  • NF-kappa B / genetics
  • NF-kappa B / metabolism*
  • Protein Transport / drug effects
  • Receptors, IgG / metabolism
  • Response Elements / genetics
  • U937 Cells

Substances

  • Antigen-Antibody Complex
  • FCGR1A protein, human
  • Immunoglobulin A
  • Immunoglobulin G
  • Lipopolysaccharides
  • NF-kappa B
  • Receptors, IgG
  • Green Fluorescent Proteins

Grants and funding

This work was funded by TÁMOP (4.2.1/B-09/1/KMR-2010-0003) awarded to Eötvös Loránd University by the European Social Fund (http://ec.europa.eu/esf/main.jsp?catId=384) and National Research, Development and Innovation Office of Hungary (http://nkfih.gov.hu/english) for supporting cell sorting experiments with FACS-ARIA III. This work was also supported by the European Union Seventh Framework Programme FP7/2007–2013 under grant agreement (GAPAID-314971, FP7-SME-2012, http://cordis.europa.eu/project/rcn/105440_en.html), entitled ‘Genes and proteins for autoimmunity diagnostics’ and OTKA grant (109683) awarded to JP by the National Research, Development and Innovation Office of Hungary (http://nkfih.gov.hu/english). KP was awarded Synergy I. Grant by the MedInProt Protein Science Research Synergy Program (http://medinprot.chem.elte.hu/). The funder (Diagnosticum Inc.) provided support in the form of salaries for authors [JP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the ‘author contributions’ section.